Intelligence

Trends & Analysis

‘Life Sciences Future50’ shines light on UK innovation

31 October 2023

PwC has published a new report on the UK life sciences industry ‘The Life Sciences Future50’, highlighting companies that illustrate world-class science and innovation, including 32 in the therapeutics space. [...]

Five UK TechBio companies driving the AI revolution

24 October 2023

The UK TechBio sector is thriving, according to a new report, with a growing number of companies pioneering ground-breaking products and services. A BioIndustry Association (BIA) report lists the widespread [...]

The considerations for building sustainable labs in pharma

19 October 2023

DDW Editor Reece Armstrong speaks to Will Fogden, UK Development Manager, Kadans Science Partner, about sustainable efforts in pharma and the considerations industry needs to take into account when developing [...]

EU’s position as vaccines leader “at risk”, report reveals

22 September 2023

The EU has historically been a leader in vaccine research, development and manufacturing, but is now seeing a decline in vaccine research, according to data published by Vaccines Europe (VE). [...]

View all trends & reports

Market Reports

Where is the drug discovery expertise happening in the UK?

16 October 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. The Golden [...]

European drug discovery and development: success stories

22 September 2023

As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? Lu Rahman highlights some of the key players. The European [...]

Antibody development drives high-value biotech deals

6 September 2023

The development of antibodies and associated technologies continues to drive high-value deals, according to a recent report in Nature.1 Using data provided by DealForma for the period 1 January 2022 [...]

Biopharma will be worth $1.6tn in 2028, analysts predict

17 August 2023

A new forecast predicts global prescription drug sales to be worth $1.6tn by 2028. Global biopharmaceutical revenues are forecast to grow at a compounded annual rate of 5.9% to 2028, [...]

View all market reports

Whitepapers & App Notes

HuPK: A Humanised Platform for therapeutic antibody PK evaluation

5 December 2023

Assessing the efficacy of vaccines through laboratory assays

28 November 2023

A comprehensive approach to immunophenotyping for targeted drug discovery and development

16 November 2023

View all Whitepapers & App Notes

Archive

Download our App

10 January 2022

Drug Discovery World is the global voice for the drug discovery community. From research stage to clinical trials the brand covers the scientific and commercial process involved in getting a [...]

Why Adopting AI is Essential for a Sustainable Pharma Industry

24 August 2020

Advancements in technology, and in particular, developments in artificial intelligence (AI) are revolutionising the way that we live our lives. Up to now, we have used it to help us [...]

The Personalized Medicine Coalition

6 August 2020

The Personalized Medicine Coalition The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized [...]

Collaborative Research Leads To New Understanding Of Biomarkers

6 August 2020

Collaborative Research Leads To New Understanding Of Biomarkers By Dr Max Ryadnov and Professor Jason Crain A new collaborative research paper sheds light on the way antibodies distinguish between different [...]

View all archives

Sidebar Banner 6

Sidebar Banner 7

Sidebar Banner 8

Sidebar Banner 12

Sidebar Banner 18

Sidebar Banner 19

Sidebar Banner 20

Sidebar Banner 21